ha powder Search Results


urea  (Chem Impex International)
95
Chem Impex International urea
Urea, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/urea/product/Chem Impex International
Average 95 stars, based on 1 article reviews
urea - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
fmoc  (Chem Impex International)
95
Chem Impex International fmoc
Fmoc, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fmoc/product/Chem Impex International
Average 95 stars, based on 1 article reviews
fmoc - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
hydroxyapatite (ha)  (Bioland Scientific)
90
Bioland Scientific hydroxyapatite (ha)
Hydroxyapatite (Ha), supplied by Bioland Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hydroxyapatite (ha)/product/Bioland Scientific
Average 90 stars, based on 1 article reviews
hydroxyapatite (ha) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
reagent-grade ha powder  (Junsei Chemical)
90
Junsei Chemical reagent-grade ha powder
Reagent Grade Ha Powder, supplied by Junsei Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/reagent-grade ha powder/product/Junsei Chemical
Average 90 stars, based on 1 article reviews
reagent-grade ha powder - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ha powder  (Genzyme)
90
Genzyme ha powder
Ha Powder, supplied by Genzyme, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ha powder/product/Genzyme
Average 90 stars, based on 1 article reviews
ha powder - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
hydroxyapatite/tricalcium phosphate (ha/tcp) ceramic powder  (Zimmer Biomet)
90
Zimmer Biomet hydroxyapatite/tricalcium phosphate (ha/tcp) ceramic powder
Hydroxyapatite/Tricalcium Phosphate (Ha/Tcp) Ceramic Powder, supplied by Zimmer Biomet, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hydroxyapatite/tricalcium phosphate (ha/tcp) ceramic powder/product/Zimmer Biomet
Average 90 stars, based on 1 article reviews
hydroxyapatite/tricalcium phosphate (ha/tcp) ceramic powder - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ha nanoparticle powder ~100 particle size and 15 m 2 /g surface area  (Nanocerox Inc)
90
Nanocerox Inc ha nanoparticle powder ~100 particle size and 15 m 2 /g surface area
Ha Nanoparticle Powder ~100 Particle Size And 15 M 2 /G Surface Area, supplied by Nanocerox Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ha nanoparticle powder ~100 particle size and 15 m 2 /g surface area/product/Nanocerox Inc
Average 90 stars, based on 1 article reviews
ha nanoparticle powder ~100 particle size and 15 m 2 /g surface area - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ha/tcp ceramic powders  (Zimmer Biomet)
90
Zimmer Biomet ha/tcp ceramic powders
MSCT rescued impaired lineage differentiation of BMMSCs in Tsk/+ mice. (A) Toluidine blue staining showing the number of CFU-F from WT control, Tsk/+, and MSCT-treated Tsk/+ BMMSCs. (B) Alizarin red staining of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs showing the capacity to form mineralized nodules when cultured under the osteoinductive conditions. (C) Western blotting analysis of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs showing the expression levels of the osteogenic genes Runx2, ALP, and OCN. β-Actin was used as a protein loading control. (D) Subcutaneous implantation of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs in immunocompromised mice showing that new bone (B) and connective tissue (CT) were generated around <t>the</t> <t>HA/TCP</t> (HA) carrier at 8 weeks post implantation. Scale bar, 50 μm. A semiquantitative analysis shows the amount of bone formation in BMMSC implants. (E) Histological images of distal femurs showing the number of adipocytes in WT, Tsk/+, and MSCT-treated Tsk/+ mouse bone marrow, as assessed by Oil red O staining. Scale bar, 50 μm. (F) The number of Oil red O+ cells in WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs under the adipoinductive conditions. (G) The expression levels of adipogenic genes PPARγ and LPL in WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs under the adipoinductive conditions. All experimental data were verified in at least three independent experiments. Error bars represent the s.d. from the mean values. ***P< 0.005; **P< 0.001; *P< 0.05.
Ha/Tcp Ceramic Powders, supplied by Zimmer Biomet, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ha/tcp ceramic powders/product/Zimmer Biomet
Average 90 stars, based on 1 article reviews
ha/tcp ceramic powders - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ha powder ceramic preparation  (Progentix bv)
90
Progentix bv ha powder ceramic preparation
MSCT rescued impaired lineage differentiation of BMMSCs in Tsk/+ mice. (A) Toluidine blue staining showing the number of CFU-F from WT control, Tsk/+, and MSCT-treated Tsk/+ BMMSCs. (B) Alizarin red staining of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs showing the capacity to form mineralized nodules when cultured under the osteoinductive conditions. (C) Western blotting analysis of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs showing the expression levels of the osteogenic genes Runx2, ALP, and OCN. β-Actin was used as a protein loading control. (D) Subcutaneous implantation of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs in immunocompromised mice showing that new bone (B) and connective tissue (CT) were generated around <t>the</t> <t>HA/TCP</t> (HA) carrier at 8 weeks post implantation. Scale bar, 50 μm. A semiquantitative analysis shows the amount of bone formation in BMMSC implants. (E) Histological images of distal femurs showing the number of adipocytes in WT, Tsk/+, and MSCT-treated Tsk/+ mouse bone marrow, as assessed by Oil red O staining. Scale bar, 50 μm. (F) The number of Oil red O+ cells in WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs under the adipoinductive conditions. (G) The expression levels of adipogenic genes PPARγ and LPL in WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs under the adipoinductive conditions. All experimental data were verified in at least three independent experiments. Error bars represent the s.d. from the mean values. ***P< 0.005; **P< 0.001; *P< 0.05.
Ha Powder Ceramic Preparation, supplied by Progentix bv, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ha powder ceramic preparation/product/Progentix bv
Average 90 stars, based on 1 article reviews
ha powder ceramic preparation - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ha powder derived from chicken combs  (Seikagaku corporation)
90
Seikagaku corporation ha powder derived from chicken combs
MSCT rescued impaired lineage differentiation of BMMSCs in Tsk/+ mice. (A) Toluidine blue staining showing the number of CFU-F from WT control, Tsk/+, and MSCT-treated Tsk/+ BMMSCs. (B) Alizarin red staining of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs showing the capacity to form mineralized nodules when cultured under the osteoinductive conditions. (C) Western blotting analysis of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs showing the expression levels of the osteogenic genes Runx2, ALP, and OCN. β-Actin was used as a protein loading control. (D) Subcutaneous implantation of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs in immunocompromised mice showing that new bone (B) and connective tissue (CT) were generated around <t>the</t> <t>HA/TCP</t> (HA) carrier at 8 weeks post implantation. Scale bar, 50 μm. A semiquantitative analysis shows the amount of bone formation in BMMSC implants. (E) Histological images of distal femurs showing the number of adipocytes in WT, Tsk/+, and MSCT-treated Tsk/+ mouse bone marrow, as assessed by Oil red O staining. Scale bar, 50 μm. (F) The number of Oil red O+ cells in WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs under the adipoinductive conditions. (G) The expression levels of adipogenic genes PPARγ and LPL in WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs under the adipoinductive conditions. All experimental data were verified in at least three independent experiments. Error bars represent the s.d. from the mean values. ***P< 0.005; **P< 0.001; *P< 0.05.
Ha Powder Derived From Chicken Combs, supplied by Seikagaku corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ha powder derived from chicken combs/product/Seikagaku corporation
Average 90 stars, based on 1 article reviews
ha powder derived from chicken combs - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ha powders  (Junsei Chemical)
90
Junsei Chemical ha powders
MSCT rescued impaired lineage differentiation of BMMSCs in Tsk/+ mice. (A) Toluidine blue staining showing the number of CFU-F from WT control, Tsk/+, and MSCT-treated Tsk/+ BMMSCs. (B) Alizarin red staining of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs showing the capacity to form mineralized nodules when cultured under the osteoinductive conditions. (C) Western blotting analysis of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs showing the expression levels of the osteogenic genes Runx2, ALP, and OCN. β-Actin was used as a protein loading control. (D) Subcutaneous implantation of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs in immunocompromised mice showing that new bone (B) and connective tissue (CT) were generated around <t>the</t> <t>HA/TCP</t> (HA) carrier at 8 weeks post implantation. Scale bar, 50 μm. A semiquantitative analysis shows the amount of bone formation in BMMSC implants. (E) Histological images of distal femurs showing the number of adipocytes in WT, Tsk/+, and MSCT-treated Tsk/+ mouse bone marrow, as assessed by Oil red O staining. Scale bar, 50 μm. (F) The number of Oil red O+ cells in WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs under the adipoinductive conditions. (G) The expression levels of adipogenic genes PPARγ and LPL in WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs under the adipoinductive conditions. All experimental data were verified in at least three independent experiments. Error bars represent the s.d. from the mean values. ***P< 0.005; **P< 0.001; *P< 0.05.
Ha Powders, supplied by Junsei Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ha powders/product/Junsei Chemical
Average 90 stars, based on 1 article reviews
ha powders - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ha powder captal s  (Plasma Biotal)
90
Plasma Biotal ha powder captal s
MSCT rescued impaired lineage differentiation of BMMSCs in Tsk/+ mice. (A) Toluidine blue staining showing the number of CFU-F from WT control, Tsk/+, and MSCT-treated Tsk/+ BMMSCs. (B) Alizarin red staining of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs showing the capacity to form mineralized nodules when cultured under the osteoinductive conditions. (C) Western blotting analysis of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs showing the expression levels of the osteogenic genes Runx2, ALP, and OCN. β-Actin was used as a protein loading control. (D) Subcutaneous implantation of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs in immunocompromised mice showing that new bone (B) and connective tissue (CT) were generated around <t>the</t> <t>HA/TCP</t> (HA) carrier at 8 weeks post implantation. Scale bar, 50 μm. A semiquantitative analysis shows the amount of bone formation in BMMSC implants. (E) Histological images of distal femurs showing the number of adipocytes in WT, Tsk/+, and MSCT-treated Tsk/+ mouse bone marrow, as assessed by Oil red O staining. Scale bar, 50 μm. (F) The number of Oil red O+ cells in WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs under the adipoinductive conditions. (G) The expression levels of adipogenic genes PPARγ and LPL in WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs under the adipoinductive conditions. All experimental data were verified in at least three independent experiments. Error bars represent the s.d. from the mean values. ***P< 0.005; **P< 0.001; *P< 0.05.
Ha Powder Captal S, supplied by Plasma Biotal, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ha powder captal s/product/Plasma Biotal
Average 90 stars, based on 1 article reviews
ha powder captal s - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


MSCT rescued impaired lineage differentiation of BMMSCs in Tsk/+ mice. (A) Toluidine blue staining showing the number of CFU-F from WT control, Tsk/+, and MSCT-treated Tsk/+ BMMSCs. (B) Alizarin red staining of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs showing the capacity to form mineralized nodules when cultured under the osteoinductive conditions. (C) Western blotting analysis of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs showing the expression levels of the osteogenic genes Runx2, ALP, and OCN. β-Actin was used as a protein loading control. (D) Subcutaneous implantation of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs in immunocompromised mice showing that new bone (B) and connective tissue (CT) were generated around the HA/TCP (HA) carrier at 8 weeks post implantation. Scale bar, 50 μm. A semiquantitative analysis shows the amount of bone formation in BMMSC implants. (E) Histological images of distal femurs showing the number of adipocytes in WT, Tsk/+, and MSCT-treated Tsk/+ mouse bone marrow, as assessed by Oil red O staining. Scale bar, 50 μm. (F) The number of Oil red O+ cells in WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs under the adipoinductive conditions. (G) The expression levels of adipogenic genes PPARγ and LPL in WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs under the adipoinductive conditions. All experimental data were verified in at least three independent experiments. Error bars represent the s.d. from the mean values. ***P< 0.005; **P< 0.001; *P< 0.05.

Journal: Cell Research

Article Title: Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis

doi: 10.1038/cr.2017.11

Figure Lengend Snippet: MSCT rescued impaired lineage differentiation of BMMSCs in Tsk/+ mice. (A) Toluidine blue staining showing the number of CFU-F from WT control, Tsk/+, and MSCT-treated Tsk/+ BMMSCs. (B) Alizarin red staining of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs showing the capacity to form mineralized nodules when cultured under the osteoinductive conditions. (C) Western blotting analysis of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs showing the expression levels of the osteogenic genes Runx2, ALP, and OCN. β-Actin was used as a protein loading control. (D) Subcutaneous implantation of WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs in immunocompromised mice showing that new bone (B) and connective tissue (CT) were generated around the HA/TCP (HA) carrier at 8 weeks post implantation. Scale bar, 50 μm. A semiquantitative analysis shows the amount of bone formation in BMMSC implants. (E) Histological images of distal femurs showing the number of adipocytes in WT, Tsk/+, and MSCT-treated Tsk/+ mouse bone marrow, as assessed by Oil red O staining. Scale bar, 50 μm. (F) The number of Oil red O+ cells in WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs under the adipoinductive conditions. (G) The expression levels of adipogenic genes PPARγ and LPL in WT, Tsk/+, and MSCT-treated Tsk/+ BMMSCs under the adipoinductive conditions. All experimental data were verified in at least three independent experiments. Error bars represent the s.d. from the mean values. ***P< 0.005; **P< 0.001; *P< 0.05.

Article Snippet: In vivo BMMSC implantation 4.0 × 10 6 BMMSCs, isolated from C57BL/6J, Tsk / + , MSCT, exosome-treated, and Ad-miR151-treated mice, were mixed with HA/TCP ceramic powders (40 mg, Zimmer Inc.) and implanted into 8-week-old nude mice subcutaneously.

Techniques: Staining, Cell Culture, Western Blot, Expressing, Generated